Fundamentals in Urology Webcast (2018)

Specifically designed for anyone unable to get away from the office to attend the Live Course - the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials. 

The Fundamentals in Urology course is designed to apply basic science knowledge and principles in development of treatment algorithms. This course will provide attendees with valuable skills in developing a rational methodological approach to application of knowledge which will contribute to positive outcomes for patients. New topics for this year include Reflux, Obstruction, and Undescended Testes- Causes and Clinical Implications and Medical and Surgical Management of ED. Attendees will discover the importance of the study of basic sciences and how it transfers into the lifelong learning process and medical practice. This course is designed to ensure a fundamental knowledge of the "why" behind a broad expanse of general urologic conditions. A thorough knowledge of the basic science behind the treatments will allow for better counseling and education of patients by all clinical urologic practitioners.

Purchase of the Fundamentals in Urology Webcast (2018) will also include additional educational resources in the following topic areas: 

  • Pathology
  • Urodynamics
  • Uro-Ethics
  • Obstructive Uropathy
  • Applications Outcome
  • Renal Physiology

Target Audience

  • Residents
  • APN/PA

Learning Objectives

After completing this activity, the learner will be able to: 

Stones, Urodynamics and Inflammation 
  1. Describe the basic pathophysiology of nephrolithiasis
  2. Identify the indications and options for the medical evaluation of recurrent and first time stone formers.
  3. Establish an effective algorithm for the medical management of nephrolithiasis.
  4. Identify the true incidence of IC/BPS and CP/CPPS in the US population
  5. Identify what is currently believed about the pathophysiology of chronic pelvic pain
  6. Describe how to use the AUA guidelines to develop a treatment plan for patients with IC/BPS and CP/CPPS
  7. Review current research in pelvic pain and possible new treatment options
  8. Apply knowledge of lower urinary tract function and electronic measurement of pressure, flow and electromyography to performance of a multichannel urodynamic test including prestudy uroflowmetry, filling cystometrogram and voiding pressure flow study
Pediatrics   
  1. Review salient concepts of vesicoureteral reflux, urinary tract obstruction and cryptorchidism with urology residents in the early stages of their urology residency training curriculum.
  2. Explain the basic development of the lower and upper urinary tract including the bladder, kidney and ureters
  3. Identify clinical situations that may be encountered if aberrant development occurs in any of the above organ systems
Urologic Imaging and Infections   
  1. Distinguish when the presence of bacteria or fungi in the urinary tract need to be treated, and when they don’t
  2. Explain the basic development of the lower and upper urinary tract including the bladder, kidney and ureters.
BPH and Science of Minimally Invasive Surgery
  1. Identify the medical therapies designed to address benign enlargement of the prostate.
  2. Explain the basic physics underlying laser energy, physiologic changes attributable to pneumoperitoneum, and mechanisms to improve outcomes of shock wave lithotripsy.
Infertility and Erectile Dysfunction 
  1. Explain male reproductive anatomy and physiology
  2. Describe a basic clinical overview of male reproductive medicine and surgery
Prostate Cancer
  1. Describe the history of M1 Prostate cancer therapies.
  2. Identify basics in ADT management.
  3. Discuss basic science and clinical outcomes of new therapies.
Bladder Neurobiology and Pelvic Organ Prolapse
  1. Review the anatomy and physiology of the lower urinary tract as it relates to bladder storage and voiding.
  2. Describe the innervation of the lower urinary tract and the principle mechanisms by which the central and peripheral nervous systems control urine storage and micturition.
  3. Explain the pathophysiological findings related to bladder dysfunction in specific neurological conditions.
  4. Discuss the pathophysiology, evaluation strategy, and treatment options for overactive bladder.
Bladder Cancer and Bowel Diversions
  1. Discuss the rationale behind selection of segment of bowel used in urinary diversion
  2. Explain the long term consequences of metabolic changes after urinary diversion and how to mitigate them
  3. Describe the surgical principle of compliance and how it relates to surgical technique
Adrenal Disorders and Kidney Cancer
  1. Define the fundamentals of adrenal anatomy and physiology integrate into the care of the urologic patient.
  2. Describe the genetic basis and current clinical and surgical management of all types of localized as well as advanced kidney cancer.
Course summary
Available credit: 
  • 33.50 AMA PRA Category 1 Credit™
  • 33.50 Non-Physician Participation
Course opens: 
06/11/2018
Course expires: 
06/11/2021
Price:
$805.00
Rating: 
0

Session 1: Stones, Urodynamics and Inflammation                                                        

  • Nephrolithiasis: Physiology, Metabolic Work‐up and Treatment of Stone, Glenn Preminger, MD
  • Urodynamics, Mikel Gray, PhD
  • Interstitial Cystitis and Disorders of Pelvic Pain, Robert J. Evans, MD, FACS

Session 2: Pediatrics                                             

  • Embryology, Congenital Anomalies, and Disorders of Sexual Differentiation, Patricio C. Gargollo, MD
  • Reflux, Obstruction, and Undescended Testes – Causes and Clinical Implications, Shukla Aseem, MD

Session 3: Urologic Imaging and Infections                                          

  • MRI for Urologist, Nabeel Sarwani, MD
  • Urologic Infections: Etiology, Patterns and Pathophysiology, Michel A. Pontari, MD

Session 4: BPH and Science of Minimally Invasive Surgery

  • BPH: Pathophysiology, Drugs, and Trial, Richard K. Lee, MD
  • Lasers, Laparoscopes, and Lithotripters: The Science of Minimally Invasive Urology, Jay D. Raman, MD, FACS

Session 5: Infertility and Erectile Dysfunction

  • Infertility and Reproductive Biology in Women and Men, Cigdem Tanrikut, MD
  • Medical and Surgical Management of ED, John Mulhall, MD
  • AUA Update, Victor Nitti, MD

Session 6: Prostate Cancer

  • PSA, Urine Markers and the Science of Cancer Screening, Leonard G. Gomella, MD, FACS
  • Management of Advanced Prostate Cancer: Drugs, Mechanisms, Disease, Epidemiology and Molecular Mechanisms, Michael B. Williams, MD

Session 7: Bladder Neurobiology and Pelvic Organ Prolapse                                                             

  • Lower Urinary Tract Neurobiology and Functional Bladder Disorders, Gary Lemack, MD
  • Pelvic Organ Prolapse and SUI: Mechanisms and Mechanics, Victor Nitti, MD

Session 8: Bladder Cancer and Bowel Diversions

  • Basic Science of Bladder Cancer, Trinity J. Bivalacqua, MD
  • Bowel Diversions: Physiology Underlying Electrolyte Abnormalities, Tracey Krupski, MD, MPH

Session 9: Adrenal Disorders and Kidney Cancer                                            

  • Adrenal Physiology, Alexander Kutikov, MD, FACS
  • Molecular Genetics and Principles of Molecular Therapeutics of Kidney Cancer, W. Marston Linehan, MD

Optional Pathology and Urdoyndamics Modules (from 2017 course)                                   

  • Pathology, Gladell Paner, MD
  • Urodynamics, Mikel Gray, PhD

Additional Educational Modules (from 2017 course)

  • Uro-Ethics, Eric A. Singer, MD
  • Obstructive Uropathy: Valves and UPJO, C.D. Anthony Herndon, MD, FAAP, FACS
  • Application of Outcomes Research to Urologic Patients, Charles D. Scales Jr., MD
  • Renal Physiology Changes in Pathologic States, Necole Marie Streeper, MD
 Faculty Disclosures:   
NameCompanyRoleFinancial
Trinity J. Bivalacqua, MDphotocureMeeting Participant or Lecturer,Scientific Study or TrialNo
tarisScientific Study or TrialNo
tarisScientific Study or TrialNo
FKDScientific Study or TrialNo
GenetechScientific Study or TrialNo
Robert J. Evans, MDallerganScientific Study or TrialYes
urigenInvestment InterestYes
allerganScientific Study or TrialYes
TARISScientific Study or TrialYes
aquinoxConsultant or Advisor,Scientific Study or TrialYes
Patricio C. Gargollo, MDIntuitive SurgicalMeeting Participant or LecturerYes
Leonard G. Gomella, MDAstellasConsultant or AdvisorYes
JanssenConsultant or AdvisorYes
Wolters KluwerHealth PublishingYes
McGraw HillHealth PublishingYes
Merck ManualHealth PublishingYes
Canadian Journal of UrologyHealth PublishingYes
MDx HealthConsultant or AdvisorYes
Merck PharmaceuticalsConsultant or AdvisorYes
BayerConsultant or AdvisorYes
Mikel L. Gray, Ph.D.Laborie MedicalScientific Study or TrialYes
3M IncConsultant or AdvisorYes
Tracey Krupski, MDArgosScientific Study or TrialNo
FKD - InstilidrinScientific Study or TrialNo
American Cancer SocietyScientific Study or TrialYes
NIHScientific Study or TrialNo
Alexander Kutikov, MDUrologyMatch.com LLCLeadership PositionYes
Visible Health, IncLeadership PositionYes
Richard K. Lee, MD 
Gary E. Lemack, MDAllerganConsultant or Advisor,Meeting Participant or LecturerYes
RoivantConsultant or AdvisorYes
AvadelConsultant or AdvisorYes
W. Marston Linehan, MD 
John P. Mulhall, MDAssociation of Peyronie's Disease Advocates (APDA)Leadership PositionNo
Victor W. Nitti, MDAstellasHealth Publishing,Scientific Study or TrialNo
AllerganHealth Publishing,Scientific Study or TrialNo
Serenity PharmeuticalsInvestment InterestYes
MedtronicScientific Study or TrialNo
Michel A. Pontari, MDLillyConsultant or AdvisorYes
aquinoxConsultant or Advisor,Scientific Study or TrialYes
Glenn M. Preminger, MDBoston ScientificConsultant or AdvisorYes
UpToDateHealth PublishingYes
RetrophinConsultant or Advisor,Meeting Participant or LecturerYes
Jay D. Raman, MDAmerican Kidney Stone ManagementInvestment InterestYes
MDx HealthScientific Study or TrialNo
Nabeel Sarwani, MD 
Aseem R. Shukla, MD 
Cigdem Tanrikut, MDNew England Cryogenic CenterOtherYes
Fertility Research and PracticeHealth PublishingNo
Michael B. Williams, M.D.AstellasScientific Study or TrialNo
JannsenScientific Study or TrialNo
Pacific Edge DiagnosticsConsultant or AdvisorYes
    
Online Educational Modules and Optional Course Faculty:   
NameCompanyRoleFinancial
Mikel L. Gray, Ph.D.Laborie MedicalMeeting Participant or LecturerYes
3M Inc.Consultant or AdvisorYes
C.D. Anthony Herndon, MD, FAAP, FACSNothing to disclose.
Gladell Paner, MDAmirsys, Inc.Health PublishingYes
Charles D. Scales Jr., MDNIH/National Institute on AgingScientific Study or TrialYes
Society of Urology Chairpersons and Program DirectorsScientific Study or TrialYes
Filament BiosolutionsScientific Study or TrialNo
NIH/ National Institute of Diabetics and Digestive and Kidney DiseasesScientific Study or TrialNo
GileadConsultant or AdvisorYes
Astra-ZenecaScientific Study or TrialYes
Eric A. Singer, MDNothing to disclose.
Necole M Streeper, M.D.Nothing to disclose.
    
Education Council Disclosures:
NameCompanyRoleFinancial
Michael R. Abern, MDDepartment of Defense Prostate Cancer Research ProgramScientific Study or TrialYes
 American Urological Association Office of EducationConsultant or AdvisorYes
 Department of Defense Prostate Cancer Research ProgramConsultant or AdvisorYes
Sero Andonian, MDLumenisMeeting Participant or Lecturer, Scientific Study or TrialYes
Timothy Charles Brand, MDNothing to disclose 
Anthony A. Caldamone, MDNothing to disclose 
Matthew S. Christman, MDNothing to disclose 
John D. Denstedt, MDCook UrologyOwner, Product DevelopmentYes
 Endourological SocietyLeadership PositionYes
 Endourological SocietyHealth PublishingYes
Jody DonaldsonNothing to disclose 
Shelby EnglertNothing to disclose 
Allen Gao, MD, PhDPandomedxLeadership Position, Owner, Product DevelopmentYes
Matthew Thomas Gettman, MDCOVR MedicalConsultant or AdvisorYes
 Intuitive SurgicalConsultant or AdvisorYes
 Exact SciencesScientific Study or TrialYes
Howard B. Goldman, MDallerganConsultant or AdvisorYes
 MedtronicConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes
 CookScientific Study or TrialNo
 NuvectraConsultant or AdvisorYes
 AxonicsConsultant or AdvisorYes
 NewUroConsultant or AdvisorYes
 GalvaniConsultant or AdvisorYes
 bionessScientific Study or TrialNo
William C. Huang, MDPhotocureScientific Study or TrialYes
 Karl StorzScientific Study or TrialYes
 IntuitiveMeeting Participant or LecturerYes
William C. Hulbert, Jr., MDNothing to disclose 
Brant Inman, MD, MS, FRCSCDendreonScientific Study or TrialNo
 Genentech IncScientific Study or TrialNo
 Combat MedicalConsultant or Advisor, Scientific Study or TrialYes
 FKD TherapiesScientific Study or TrialNo
 NucleixScientific Study or TrialYes
 UrogenScientific Study or TrialYes
Mark L. Jordan MD,FACSNothing to disclose 
Martin A. Koyle, MDNothing to disclose 
Yair Lotan, MDabbottScientific Study or TrialNo
 CepheidConsultant or Advisor, Scientific Study or TrialNo
 Pacific EdgeScientific Study or TrialNo
 FKDScientific Study or TrialNo
 MDxHealthConsultant or Advisor, Scientific Study or TrialYes
 biocancellScientific Study or TrialNo
 GenomeDx Biosciences IncScientific Study or TrialNo
 photocureConsultant or Advisor, Scientific Study or TrialNo
Nicole Lara Miller, MDBoston Scientific CorporationConsultant or Advisor, Meeting Participant or LecturerYes
 Practical Reviews In UrologyHealth PublishingYes
Manoj Monga, MD, FACSFortecOtherYes
Ajay Kumar Nangia, MBBS, FACSAUA NewsLeadership Position, Health PublishingYes
NIH CCN TrialScientific Study or TrialYes
Urology Care FoundationLeadership PositionNo
AUA Health Policy CouncilLeadership PositionNo
South Central AUALeadership PositionNo
ASRMLeadership PositionNo
Curtis Nickel, MDFarr LaboratoriesConsultant or AdvisorYes
AquinoxScientific Study or TrialNo
PureTech HealthConsultant or AdvisorYes
AUAHealth PublishingYes
NIHScientific Study or TrialYes
Canadian Institute of Health ResearchScientific Study or TrialYes
Interface BiologicsConsultant or AdvisorYes
Alvio TherapeuticsConsultant or AdvisorYes
Seikagaku CorporationConsultant or AdvisorYes
MedifocusConsultant or AdvisorYes
RedLeaf MedicalConsultant or AdvisorYes
Victor William Nitti, MDAstellasHealth Publishing, Scientific Study or TrialNo
AllerganHealth Publishing, Scientific Study or TrialNo
Serenity PharmeuticalsInvestment InterestYes
MedtronicScientific Study or TrialNo
Christopher Porter, MDNothing to disclose 
Ganesh V. Raj, MD, PhDPtaresOwner, Product DevelopmentYes
 C-diagnostics corpConsultant or Advisor, Investment InterestYes
 amgenMeeting Participant or LecturerYes
 Johnson and JohnsonConsultant or Advisor, Owner, Product DevelopmentYes
 AstellasMeeting Participant or LecturerYes
 ASTELLASConsultant or Advisor, Meeting Participant or LecturerYes
 JanssenOwner, Product DevelopmentYes
 BAYERConsultant or Advisor, Meeting Participant or LecturerYes
 SANOFIConsultant or Advisor, Meeting Participant or LecturerYes
 GaudiumRxLeadership Position, Investment Interest, Owner, Product DevelopmentYes
 MedivationConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes
 EtiraRxLeadership Position, Investment Interest, Owner, Product DevelopmentYes
Jay D. Raman, MDAmerican Kidney Stone ManagementInvestment InterestYes
MDx HealthScientific Study or TrialNo
Lee Richstone, MDNothing to disclose 
Heather SchultzSUNAMeeting Participant or LecturerYes
 SUNALeadership PositionNo
Karl-Dietrich Sievert, MD, PhDMedtronicsMeeting Participant or Lecturer, Scientific Study or TrialYes
 AllergenConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes
 NeotractMeeting Participant or LecturerYes
 StimguardMeeting Participant or Lecturer, Scientific Study or TrialYes
Joseph A. Smith Jr., MDNothing to disclose 
Ryan Patrick Terlecki, MD, FACSAmerican Medical SystemsConsultant or Advisor, OtherYes
 Boston ScientificConsultant or AdvisorYes
 MicroGen DxConsultant or AdvisorYes
 U.S. Department of DefenseScientific Study or TrialYes
Edouard John Trabulsi, MD, FACSGenomeDxConsultant or AdvisorYes
 JanssenConsultant or Advisor, Meeting Participant or LecturerYes
 PfizerConsultant or Advisor, Meeting Participant or LecturerYes
 MerckMeeting Participant or LecturerYes

Method of Participation: Learners will participate in this online educational activity by viewing the webcast and completing the posttest and evaluation. To claim CME credit for this enduring material, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.

Estimated time to complete this activity: 33.5 hours

Release Date: June, 2018
Expiration Date: June, 2021

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The American Urological Association designates this enduring activity for a maximum of 30.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Available Credit

  • 33.50 AMA PRA Category 1 Credit™
  • 33.50 Non-Physician Participation

Accreditation Period

Course opens: 
06/11/2018
Course expires: 
06/11/2021
 
Status
Price
Title
$805.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.

Price

Price:
$805.00
Please login or register to take this course.